Loading...
•
Jun 30, 2025
Cigna Q2 2025 Earnings Report
Cigna reported strong Q2 2025 results with solid revenue growth and reaffirmed its full-year adjusted EPS outlook.
Key Takeaways
Cigna delivered strong Q2 2025 performance, led by continued growth in Evernorth Health Services and reaffirmation of full-year EPS guidance.
Revenue rose to $67.2 billion, up from $60.5 billion in Q2 2024.
Adjusted EPS grew to $7.20 from $6.72 year over year.
Net income was steady at $1.5 billion compared to the prior year.
Strong specialty pharmacy growth and client relationship expansion fueled Evernorth performance.
Revenue by Segment
Forward Guidance
Cigna reaffirmed its full-year 2025 outlook for adjusted income from operations of at least $29.60 per share.
Positive Outlook
- Full-year adjusted EPS outlook reaffirmed at $29.60+.
- Evernorth expected to deliver at least $7.2B in pre-tax adjusted income.
- Cigna Healthcare projected to contribute $4.125B pre-tax adjusted income.
- Expected continued strong specialty pharmacy growth.
- Revenue and earnings outlook includes share repurchases and dividends.
Challenges Ahead
- Higher stop loss medical costs impacting Cigna Healthcare margins.
- Decline in Cigna Healthcare revenue due to Medicare divestiture.
- Higher medical care ratio forecasted between 83.2%-84.2%.
- Evernorth income growth moderated by lower investment income.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...